Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shaughnessy

Showing results (111-120 of 194) with videos related to

Pageof 20
Sort By:
Blood|May 23, 2007
Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myelomaJianfei Qian, Jin Xie, Sungyoul Hong, et al.
The Journal of Biological Chemistry|March 10, 2007
Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasisYang Yang, Veronica Macleod, Hua-Quan Miao, et al.
European Journal of Haematology|February 5, 2009
High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosisAnne-Tove Brenne, Unn-Merete Fagerli, John D Shaughnessy, et al.
Blood Advances|February 12, 2025
Prior exposure to belantamab mafodotin influences outcomes with idecabtagene vicleucel in patients with multiple myelomaBhavesh Mohan Lal, Marah Alzubi, Jawad Alrawabdeh, et al.
Blood|October 23, 2013
Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120)Madhav V Dhodapkar, Rachael Sexton, Sarah Waheed, et al.
Haematologica|September 4, 2025
The invisible divide: the impact of racial and geographic disparities on multiple myeloma outcomes - insights from a single-site studyMichael A Bauer, Phillip Farmer, Joseph L Su, et al.
Blood|May 27, 2008
First thalidomide clinical trial in multiple myeloma: a decadeFrits van Rhee, Madhav Dhodapkar, John D Shaughnessy, et al.
Blood|October 7, 2006
Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosisFenghuang Zhan, Bart Barlogie, Varant Arzoumanian, et al.
BMC Genomics|September 4, 2007
Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasiaEun Sung Park, John D Shaughnessy, Shalu Gupta, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 20, 2008
Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myelomaDeborah J Heath, Andrew D Chantry, Clive H Buckle, et al.
Pageof 20

Showing results (111-120 of 194) with videos related to

Sort By:
Pageof 20
Blood|May 23, 2007
Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myelomaJianfei Qian, Jin Xie, Sungyoul Hong, et al.
The Journal of Biological Chemistry|March 10, 2007
Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasisYang Yang, Veronica Macleod, Hua-Quan Miao, et al.
European Journal of Haematology|February 5, 2009
High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosisAnne-Tove Brenne, Unn-Merete Fagerli, John D Shaughnessy, et al.
Blood Advances|February 12, 2025
Prior exposure to belantamab mafodotin influences outcomes with idecabtagene vicleucel in patients with multiple myelomaBhavesh Mohan Lal, Marah Alzubi, Jawad Alrawabdeh, et al.
Blood|October 23, 2013
Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120)Madhav V Dhodapkar, Rachael Sexton, Sarah Waheed, et al.
Haematologica|September 4, 2025
The invisible divide: the impact of racial and geographic disparities on multiple myeloma outcomes - insights from a single-site studyMichael A Bauer, Phillip Farmer, Joseph L Su, et al.
Blood|May 27, 2008
First thalidomide clinical trial in multiple myeloma: a decadeFrits van Rhee, Madhav Dhodapkar, John D Shaughnessy, et al.
Blood|October 7, 2006
Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosisFenghuang Zhan, Bart Barlogie, Varant Arzoumanian, et al.
BMC Genomics|September 4, 2007
Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasiaEun Sung Park, John D Shaughnessy, Shalu Gupta, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 20, 2008
Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myelomaDeborah J Heath, Andrew D Chantry, Clive H Buckle, et al.
Pageof 20